Literature DB >> 32361467

UPLC-based assay to assess the hydrophobicity of Antibody-Drug Conjugate (ADC) payloads.

Ilona Pysz1, Paul J M Jackson2, David J Barlow3, Khondaker Miraz Rahman1, David E Thurston4.   

Abstract

Antibody-Drug Conjugates (ADCs) consist of antibodies attached to cytotoxic small molecules or biological agents (i.e., payloads) through chemical linkers which may be cleavable or non-cleavable. The development of new ADCs is challenging, particularly the process of attaching the linker-payload construct to the antibody (i.e., the conjugation process). One of the major problems associated with conjugation is high hydrophobicity of the payload which can lead to low yields of the ADC through aggregation and/or lower than desired Drug-Antibody Ratios (DARs). We report here a UPLC-based assay that can be used to study the physicochemical properties of ADC payloads at an early stage of development, and to provide information on whether the hydrophilic-hydrophobic balance is suitable for conjugation or further physicochemical optimization is required. The assay is relatively simple to establish and should be of use to those working in the ADC area.
Copyright © 2020 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  ADC payload; Aggregation; Analytical method development; Antibody Drug Conjugate (ADC); Conjugation; High-Performance Liquid Chromatography (HPLC); Hydrophobicity; Ultra-Performance Liquid Chromatography (UPLC)

Year:  2020        PMID: 32361467     DOI: 10.1016/j.jchromb.2020.122075

Source DB:  PubMed          Journal:  J Chromatogr B Analyt Technol Biomed Life Sci        ISSN: 1570-0232            Impact factor:   3.205


  1 in total

Review 1.  Risk Minimization of Antibody-Drug Conjugates in Oncology: A Review.

Authors:  Fabio A Lievano; Linda J Scarazzini; Jerzy E Tyczynski; Charles M Schubert; Cheryl L Renz
Journal:  Drug Saf       Date:  2021-05-14       Impact factor: 5.606

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.